Post-graduate theses
Search command : Author="Μπριασούλης"
And Author="Γεώργιος"
Current Record: 766 of 1204
|
Identifier |
000382537 |
Title |
Study of the expression and function of negative immunomodulatory receptors of B lymphocytes in healthy controls and patients with systemic lupus erythematosus |
Alternative Title |
Μελέτη της έκφρασης και της λειτουργίας αρνητικών ανοσορρυθμιστικών υποδοχέων των Β λεμφοκυττάρων σε υγιείς και ασθενείς με συστηματικό ερυθηματώδη λύκο |
Author
|
Ζαμπουλάκη, Αμαλία Γ.
|
Thesis advisor
|
Μπερτσιάς, Γεώργιος
|
Reviewer
|
Σιδηρόπουλος, Πρόδρομος
Τσατσάνης, Χρήστος
|
Abstract |
Systemic Lupus Erythematosus (SLE) is a systemic autoimmune disorder characterized by the presence of high-titer autoantibodies produced by long-lived plasma cells. Evidence from in vivo and in vitro studies have established activated B cells as an important component of its pathogenesis. Optimal B cell activation and differentiation requires convergent signals from the B cell receptor (BcR), Toll-like receptors (TLRs) as well as costimulatory molecules, whereas B cells can also be influenced by inhibitory immunoreceptors, such as B and T lymphocyte Attenuator (BTLA), Programmed cell death protein 1 (PD-1) and Programmed cell death 1 ligand 1 (PD-L1). This study aimed at investigating the expression and function of the coinhibitory receptors BTLA, PD-1 and PD-L1 in B cells from healthy donors and active SLE patients. BTLA, PD-1 and PD-L1 expression was examined by flow cytometry in peripheral blood naïve (CD19+IgD+CD27-), transitional (CD19+IgD+CD27+), memory (CD19+IgD-CD27+) and plasma B cells (CD19+IgD-CD27hi) at basal state and in purified peripheral blood CD19+ B cells following stimulation. BTLA ligand, HVEM (Herpes Virus Entry Mediator), expression was also considered in peripheral blood CD4+ T cells. Activation, differentiation, proliferation and IL-6 production of B cells were examined in the presence or absence of the BTLA ligand, HVEM. Analysis resulted in differential baseline expression of all three receptors studied in B cell subsets both in healthy donors and in SLE patients. HVEM levels were found to be significantly increased in SLE CD4+ T cells. BcR activation enhanced the expression all three receptors in normal B-cells; addition of CpG-ODN (TLR9 ligand) further induced PD-1 and PD-L1 –but not BTLA– expression, whereas addition of the cytokines IL-4, IL-10 or IL-21 reduced PD-1 and BTLA levels. In vitro cross linking of BTLA with HVEM resulted in decreased expression of activation markers CD80/CD86 and differentiation, in attenuation of B cell proliferation, although it had a differential effect on IL-6 production in B cells from SLE patients compared to healthy controls. In conclusion, these data demonstrate a different pattern of expression of BTLA, PD-1 and PD-L1 among B cell subsets and upon treatment with stimuli, with important implications for the modulation of B cell activation and differentiation.
14
Aberrancies in the expression and function of coinhibitory receptors in B cells could contribute to enhanced autoantibody-forming capacity and disease pathogenesis.
|
Language |
English |
Subject |
B lymphocytes |
|
BTLA |
|
HVEM |
|
Negative immunomodullatory receptors |
|
PD-1 |
|
PD-L1 |
|
Systemic lupus erythematosus |
|
Αρνητικοί ανοσορρυθμιστικοί υποδοχείς |
|
Βλεμφοκύτταρα |
|
Συστηματικός ερυθηματώδης λύκος |
Issue date |
2013-07-16 |
Collection
|
School/Department--School of Medicine--Department of Medicine--Post-graduate theses
|
|
Type of Work--Post-graduate theses
|
Permanent Link |
https://elocus.lib.uoc.gr//dlib/0/f/a/metadata-dlib-1392024084-137236-8058.tkl
|
Views |
324 |